(Sec. 1) This bill requires the Department of Health and Human Services to convene a Pain Management Best Practices Inter-Agency Task Force to: (1) review, modify, and update best practices for pain management and prescribing pain medication; and (2) examine and identify the need for, development of, and availability of medical alternatives to opioids (drugs with effects similar to opium, such as certain pain medications).
The task force must submit a report that includes: (1) the modified and updated best practices; (2) a strategy for disseminating the best practices; (3) the feasibility of linking the best practices to Drug Enforcement Administration registration of manufacturers, distributors, and dispensers of controlled substances; (4) recommendations for effectively applying the best practices at medical facilities; and (5) recommendations regarding medical alternatives to opioids.
[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4641 Introduced in House (IH)]
<DOC>
114th CONGRESS
2d Session
H. R. 4641
To provide for the establishment of an inter-agency task force to
review, modify, and update best practices for pain management and
prescribing pain medication, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 26, 2016
Mrs. Brooks of Indiana (for herself and Mr. Kennedy) introduced the
following bill; which was referred to the Committee on Energy and
Commerce
_______________________________________________________________________
A BILL
To provide for the establishment of an inter-agency task force to
review, modify, and update best practices for pain management and
prescribing pain medication, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. DEVELOPMENT OF BEST PRACTICES FOR THE USE OF PRESCRIPTION
OPIOIDS.
(a) Definitions.--In this section--
(1) the term ``Secretary'' means the Secretary of Health
and Human Services; and
(2) the term ``task force'' means the Pain Management Best
Practices Inter-Agency Task Force convened under subsection
(b).
(b) Inter-Agency Task Force.--Not later than December 14, 2018, the
Secretary, in cooperation with the Secretary of Veterans Affairs, the
Secretary of Defense, and the Administrator of the Drug Enforcement
Administration, shall convene a Pain Management Best Practices Inter-
Agency Task Force to review, modify, and update, as appropriate, best
practices for pain management (including chronic and acute pain) and
prescribing pain medication.
(c) Membership.--The task force shall be comprised of--
(1) representatives of--
(A) the Department of Health and Human Services;
(B) the Department of Veterans Affairs;
(C) the Food and Drug Administration;
(D) the Department of Defense;
(E) the Drug Enforcement Administration;
(F) the Centers for Disease Control and Prevention;
(G) the National Academy of Medicine;
(H) the National Institutes of Health; and
(I) the Office of National Drug Control Policy;
(2) physicians, dentists, and nonphysician prescribers;
(3) pharmacists;
(4) experts in the fields of pain research and addiction
research;
(5) representatives of--
(A) pain management professional organizations;
(B) the mental health treatment community;
(C) the addiction treatment community;
(D) pain advocacy groups; and
(E) groups with expertise around overdose reversal;
(6) a person in recovery from addiction to medication for
chronic pain;
(7) a person with chronic pain; and
(8) other stakeholders, as the Secretary determines
appropriate.
(d) Duties.--The task force shall--
(1) not later than 180 days after the date on which the
task force is convened under subsection (b), review, modify,
and update, as appropriate, best practices for pain management
(including chronic and acute pain) and prescribing pain
medication, taking into consideration--
(A) existing pain management research;
(B) recommendations from relevant conferences and
existing relevant evidence-based guidelines;
(C) ongoing efforts at the State and local levels
and by medical professional organizations to develop
improved pain management strategies, including
consideration of the availability of opioids with abuse
deterrent technology as well as pharmacological and
medical device alternatives to opioids to reduce opioid
monotherapy in appropriate cases;
(D) the management of high-risk populations, other
than populations who suffer pain, who--
(i) may use or be prescribed
benzodiazepines, alcohol, and diverted opioids;
or
(ii) receive opioids in the course of
medical care; and
(E) the Proposed 2016 Guideline for Prescribing
Opioids for Chronic Pain issued by the Centers for
Disease Control and Prevention (80 Fed. Reg. 77351
(December 14, 2015)) and any final guidelines issued by
the Centers for Disease Control and Prevention;
(2) solicit and take into consideration public comment on
the practices developed under paragraph (1), amending such best
practices if appropriate; and
(3) develop a strategy for disseminating information about
the best practices developed under paragraphs (1) and (2) to
prescribers, pharmacists, State medical boards, educational
institutions that educate prescribers and pharmacists, and
other parties, as the Secretary determines appropriate.
(e) Limitation.--The task force shall not have rulemaking
authority.
(f) Report.--Not later than 270 days after the date on which the
task force is convened under subsection (b), the task force shall
submit to Congress a report that includes--
(1) the strategy for disseminating best practices for pain
management (including chronic and acute pain) and prescribing
pain medication, as developed under subsection (d);
(2) the results of a feasibility study on linking the best
practices described in paragraph (1) to receiving and renewing
registrations under section 303(f) of the Controlled Substances
Act (21 U.S.C. 823(f)); and
(3) recommendations for effectively applying the best
practices described in paragraph (1) to improve prescribing
practices at medical facilities, including medical facilities
of the Veterans Health Administration.
<all>
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Pallone Part A amendment no. 5.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Nolan Part A amendment no. 6.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Watson Coleman Part A amendment no. 7.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Kuster Part A amendment no. 8.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Schiff Part A amendment no. 9.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Clark (MA) Part A amendment no. 10.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Rothfus Part A amendment no. 11.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Clark (MA) Part A amendment no. 12.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Esty Part A amendment no. 13.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Welch Part A amendment no. 14.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Sessions Part A amendment no. 15.
The House rose from the Committee of the Whole House on the state of the Union to report H.R. 4641.
The previous question was ordered pursuant to the rule. (consideration: CR H2247)
The House adopted the amendment in the nature of a substitute as agreed to by the Committee of the Whole House on the state of the Union. (text of amendment in the nature of a substitute: CR H2238)
POSTPONED PROCEEDINGS - At the conclusion of debate H.R. 4641, the Chair put the question on passage of the bill, and by voice vote announced that the ayes had prevailed. Mrs. Brooks (IN) demanded the yea and nays, and the Chair postponed further proceedings on the question of passage until a time to be announced.
Considered as unfinished business. (consideration: CR H2253)
Passed/agreed to in House: On passage Passed by the Yeas and Nays: 412 - 4 (Roll no. 184).
Roll Call #184 (House)On passage Passed by the Yeas and Nays: 412 - 4 (Roll no. 184).
Roll Call #184 (House)Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.